A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab
The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about…
Idarucizumab
-
A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab
The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about... -
New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab
Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved... -
Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More
Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum...
New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab
Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved…
Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More
Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum…
Results Confirm Idarucizumab’s Ability to Restore Clotting in Dabigatran Recipients
The blood thinning effects of dabigatran (Pradaxa) can be quickly and reliably reversed by giving idarucizumab (Praxbind)…
Current Issue
More from this issue
Polls
With regard to state legislative activity regulating the opioid prescribing practices of emergency physicians, which of the following wouId you support? Check all that apply.
- Restrictions on duration (36%, 229 Votes)
- Restrictions of quantity (34%, 219 Votes)
- Mandatory checking of prescription drug monitoring systems for all opioid prescriptions from the ED (30%, 194 Votes)
Total Voters: 367
Loading ...